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Edited by Beat ImhofAbstract The immune cell speciﬁc protein Fyn-T binding pro-
tein (Fyb) has been identiﬁed as a target of the Yersinia anti-
phagocytic eﬀector Yersinia outer protein H (YopH), but its
role in macrophages is unknown. By using Fyb domains as bait
to screen a mouse lymphoma cDNA library, we identiﬁed a novel
interaction partner, mammalian actin binding protein 1
(mAbp1). We show that mAbp1 binds the Fyb N-terminal via
its C-terminally located src homology 3 domain. The interaction
between Fyb and mAbp1 is detected in macrophage lysates and
the proteins co-localize with F-actin in the leading edge. Hence,
mAbp1 is likely to constitute a downstream eﬀector of Fyb in-
volved in F-actin dynamics.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Fyn-T binding protein (Fyb, also denoted SLAP-130 or
ADAP) has been identiﬁed as a target of the Yersinia antiphag-
ocytic factor, Yersinia outer protein H (YopH), in macro-
phages [1]. The protein tyrosine phosphatase (PTPase)
YopH, is an essential virulence factor of pathogenic Yersinia
species that invades lymphatic tissue and evades the primary
immune defence [2]. When Yersinia interacts with target cells,
YopH together with other Yop eﬀectors are delivered into host
cells via a type III secretion/translocation mechanism [3]. Mac-
rophages, which constitute the ﬁrst line of defence in lymphoid
tissues, are considered as the major target cells for the anti-
phagocytic eﬀect of Yersinia. YopH is one of the ﬁrst eﬀectorsAbbreviations: YopH, Yersinia outer protein H; mAbp1, mammalian
actin binding protein 1; SH3, src homology 3; Fyb, Fyn-T binding
protein; PTPase, protein tyrosine phosphatase; Cas, p130 Crk asso-
ciated substrate; SKAP-HOM, SKAP-55 homology protein; SLAP-
130, SLP-76 associated protein of 130 kDa; ADAP, adhesion and
degranulation promoting adaptor protein; SLP-76, SH2 domain-con-
taining leukocyte phosphoprotein of 76 kDa; EVH1, Ena/VASP
homology 1; Ena/VASP, enabled/vasodilator-stimulated phosphopro-
tein; WASP, Wiskott–Aldrich syndrome protein; HIP-55, haematopo-
etic progenitor kinase 1 interacting protein of 55 kDa; RT, reverse
transcription; GST, glutathione S-transferase; MYM, multiple yop
mutant; ADF-H, actin-depolymerizing factor homology; UMM, ulti-
mate mountingmedia; Arp, actin related protein; SKAP-55, Src-kinase-
associated protein of 55 kDa
*Corresponding author. Fax: +46 90 772630.
E-mail address: maria.fallman@molbiol.umu.se (M. Fa¨llman).
0014-5793/$30.00  2005 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2005.03.031that enter into the cell, and its PTPase activity is required for
phagocytic blockage and for Yersinia virulence in mice [4–6].
Phagocytosis is an actin-dependent process mediated by
diﬀerent receptors and the blocking by YopH includes phago-
cytosis mediated by integrins as well as Fc receptors [7]. Non-
opsonized Yersinia binds to b1-integrins of host cells via the
surface located protein, invasin [8]. This binding initiates sig-
nalling to the cytoskeleton that results in actin reorganization,
which in the absence of YopH allows engulfment of the surface
attached bacteria. When YopH is present and injected into the
cells, this PTPase rapidly dephosphorylates certain tyrosine-
phosphorylated proteins and this is associated with impaired
phagocytosis [9,10]. In macrophages, the substrates of YopH
are p130 Crk associated substrate (Cas), SKAP-55 homology
protein (SKAP-HOM) and Fyb [1,11–13], also known as
SLP-76 associated protein of 130 kDa (SLAP-130) [14] or
adhesion and degranulation promoting adaptor protein
(ADAP) [15].
The ﬁnding of Fyb as a target of YopH in macrophages is
especially intriguing since expression of this adapter protein
is restricted to immune cells. Fyb is expressed in T cells, mast
cells, monocytes, platelets, but not B cells [16]. There are two
Fyb isoforms of 120 and 130 kDa that diﬀer because of a 46
amino acid insert in the C-terminus of the 130 kDa form
[17]. Fyb is an adaptor protein that contains several regions
with potential to mediate protein-protein interactions; these in-
clude several proline-rich motifs in the N-terminal half of the
protein and a C-terminal src homology 3 (SH3)-like domain.
In addition, Fyb also has two putative nuclear localization se-
quences and multiple tyrosine containing motifs. Two YDDV
motifs have been shown to be tyrosine-phosphorylated by Fyn
kinase, which is important for the binding to the SH2 domain-
containing leukocyte phosphoprotein of 76 kDa (SLP-76)
[14,17]. Fyb also contains a FPPPP motif, which has been re-
ported to bind the Ena/VASP homology 1 (EVH1) domain of
enabled/vasodilator-stimulated phosphoprotein (Ena/VASP),
a family of actin binding and regulating proteins [18–20].
Most studies of Fyb have been focused on T cells, which is
the cell type where Fyb was initially found. Several reports
have suggested a role for Fyb in integrin-associated actin orga-
nization where Fyb inﬂuences the avidity of both b2 and b1
integrins [15,21–23]. Fyb / T cells fail to enhance integrin-
dependent adhesion but T cell receptor (TCR) induced actin
polymerization is normal [24,25]. In agreement with this,
Fyb has been found to co-localize with F-actin in membrane
ruﬄes, adhesion plaques/podosomes and phagocytic cups
[15,26,27]. The identiﬁcation of Fyb as a ligand for the
EVH1 domain of the actin-binding Ena/VASP proteins [18]blished by Elsevier B.V. All rights reserved.
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cellular structures rich in actin dynamics. It was also shown
that Fyb became tyrosine-phosphorylated upon TCR stimula-
tion and formed a complex with Wiskott–Aldrich syndrome
protein (WASP), VASP, Nck and SLP-76 [18,28]. The role
of Fyb in macrophages is largely unknown, but the ﬁnding that
this adaptor protein is rapidly dephosphorylated by the Yer-
sinia antiphagocytic eﬀector, YopH, suggests a role for this
adaptor protein in macrophage phagocytosis.
In this paper, we describe the identiﬁcation of mammalian
actin binding protein 1 (mAbp1), also known as SH3p7 or hae-
matopoietic progenitor kinase 1 interacting protein of 55 kDa
(HIP-55) [29–31] as a new interaction partner of Fyb. We show
that the proline rich N-terminal half of Fyb binds to the SH3
domain of mAbp1 and thus this interaction might be one
mechanism through which Fyb inﬂuences actin reorganization
in macrophages.2. Materials and methods
2.1. Cell culture
Mouse macrophage-like J774 cells were maintained in a-MEM (Sig-
ma) supplemented with 10% fetal bovine serum (Invitrogen BV),
100 U/ml penicillin and 100 lg/ml streptomycin (Invitrogen) at 37 C
in a humidiﬁed atmosphere with 5% CO2.
2.2. Antibodies
HRPO-conjugated anti-phosphotyrosine antibody RC20 (Trans-
duction Laboratories) was used at a dilution of 1:2500 (v/v) for
immunoblotting. Mouse monoclonal anti-His antibody (Amersham
Bioscience) was used at a dilution of 1:3000 (v/v) for immunoblot-
ting. Rabbit polyclonal anti-Fyb antiserum was kindly provided by
Dr. Klemens Rottner (GBF, Germany) and used at a dilution of
1:1000 (v/v) for immunoblotting. GST-mAbp1 1-433 was digested
with PreScission protease (Amersham Bioscience) and used to raise
polyclonal rabbit antiserum and hen IgY (Agrisera AB, Umea˚, Swe-
den). Both the antiserum and the puriﬁed hen IgY recognized both
human and mouse mAbp1.
The following secondary antibodies were used: HRPO-conjugated
sheep anti-mouse or donkey anti-rabbit antibodies (1:10000) (Amer-
sham Bioscience, UK), HRPO-conjugated rabbit anti-chicken IgY
(1:50000) (Sigma), FITC-conjugated swine anti-rabbit antibodies
(1:100) (Jackson Immuno Research Laboratories Inc.), TRITC- or
FITC-conjugated donkey anti-chicken IgY (1:100) (Jackson Immuno
Research Laboratories Inc.).
For blocking non-speciﬁc staining, 5% normal donkey serum was
used (Jackson Immuno Research Laboratories Inc.). For staining of
F-actin, 1–2 U/ml phalloidin (Alexa 568 phalloidin; Molecular Probes)
was used.
2.3. Construction of GFP-Fyb variants and transfection of J774 cells
Fragments encoding amino acids 1–547, 548–783, 1–783 of Fyb
(numbering according to [14,16]) were generated by PCR and cloned
into the pCB6 N-GFP vector (kindly provided by Dr. M. Way, EMBL,
Heidelberg, Germany [32]). The resulting constructs pCB6GFP-Fyb 1-
783 (full length), pCB6GFP-Fyb 1-547, and pCB6GFP-Fyb 548-783
were veriﬁed by sequencing. J774 cells were plated onto 12 mm glass
cover slips and grown for 1 day before transfection; cells were incu-
bated with a mixture of 3.6 ll of FuGENE 6 reagent (Roche Diagnos-
tics Scandinavia AB) and 0.4 lg of plasmids for 48 h before
immunoﬂuorescence assay.
2.4. Yeast two-hybrid assays
Fragments encoding amino acids 1–339, 341–598, 548–783 of Fyb
(numbering according to [14,16]) were generated by PCR and cloned
into the pGBKT7 (TRP1 nutritional marker changed to URA3) vector
(kindly provided by Dr. Anders Bystro¨m, Department of Molecular
Biology, Umea˚ University, Sweden) to create a fusion protein with aGAL4 DNA-binding domain. Mouse lymphoma MATCHMAKER
cDNA library (BD Biosciences) and the diﬀerent Fyb constructs were
transformed into the yeast strain UMY1974 (MATa trp1-901 leu2-3,
112 ura3-52 his3-200 gal4 gal80 GAL2-ADE2, LYS2::GAL1-HIS3
met2::GAL7-lacZ) (kindly provided by Dr. Anders Bystro¨m, Depart-
ment of Molecular Biology, Umea˚ University, Sweden) by the lithium
acetate method described by the manufacturer (BD Biosciences). Posi-
tive clones were detected by plating on synthetic medium in the ab-
sence of leucine, histidine, uracil and adenine. Plasmids of positive
clones were isolated and retransformed to conﬁrm the results and ﬁnally
veriﬁed by sequencing. The b-galactosidase activities of positive clones
were measured using the SDS–chloroform method [33].2.5. Reverse transcription (RT)-PCR
J774 cells mRNA templates were isolated using the Fast Trak kit 2.0
mRNA isolation system (Invitrogen). Primers (5 0-CCG GAA TTC
CTC TAT GAG CTC CAC GTA GT-3 0) and (5 0-CGC GGA TCC
ATG GCG GTG AAC CTG AGC C-3 0) for mAbp1 were used for
RT-PCR using the Titan one tube RT-PCR system (Roche Diagnos-
tics Scandinavia AB). The PCR products were run on 1% agarose
gel then stained with ethidium bromide. The 1.3 kb band was cut
and puriﬁed DNA was cloned into pGEX-Teasy vector (Promega)
and sequenced.2.6. GST and his fusion proteins
Fragments encoding amino acids 1–339, 341–598, 548–783 of Fyb
were generated by PCR and cloned into the pTrcHisA vector (Invit-
rogen). Fragments encoding amino acids 1–146, 1–280, 281–433,
371–433, 1–433 of mAbp1 were generated by PCR and cloned into
the pGEX-6p-1 vector (Amersham Biosciences). The resulting plas-
mids were transformed into BL-21 (Stratagene), BL-21 star (DE3)
(Invitrogen) or TKX1 (Stratagene). Expression of glutathione S-
transferase (GST) and His fusion proteins were induced with 0.5
mM of IPTG in the bacteria cultures. Lysates were prepared by
sonication. For His fusion proteins, the lysates were separated by
SDS–PAGE and transferred onto PVDF membranes (Millipore Cor-
poration), then immunoblotted with anti-pTyr or anti-His antibod-
ies. GST fusion proteins were puriﬁed on glutathione Sepharose
4B beads according to the manufacturers instructions (Amersham
Bioscience). The GST fusion proteins were separated by SDS–PAGE
then stained with Coomassie blue or transferred onto PVDF mem-
brane and immunoblotted with anti-pTyr antibodies. The GST-
mAbp1W/A point mutant, where the tryptophan411 was exchanged
for alanine, was generated by oligo-based PCR mutagenesis using
the QuickChange Site-Directed Mutagenesis kit (Stratagene) accord-
ing to the manufacturers instructions. All mutations and trunca-
tions were veriﬁed by sequencing.
2.7. GST pull down
GST-mAbp1 was puriﬁed on glutathione Sepharose 4B beads
(Amersham Bioscience). For pull down of Fyb from J774 lysates,
10 lg of GST-mAbp1 proteins bound to beads were added to 1 mg
of lysates. For pull downs of His-Fyb fusion proteins from bacterial
lysates, 5 lg of GST-mAbp1 proteins bound to beads were added to
50 lg of crude lysates in 1 ml of lysis buﬀer (PBSA, pH 8.0, 1% Triton
X-100, 0.2 mM AEBSF) and incubated at 4 C for 2 h with shaking.
The beads were pelleted by centrifugation and washed three times with
1 ml of ice-cold RIPA or lysis buﬀer, then resuspended in 2 · Laemm-
lie sample buﬀer and boiled. The samples were separated by SDS–
PAGE, transferred onto PVDF membranes, and immunoblotted [1]
with anti-His antibody.
2.8. Bacterial strains and growth conditions
The plasmids encoding wild-type YopH (pyopH [34]) and the
PTPase inactivated YopH (pyopH403C/A [34]) were isolated by stan-
dard methods and introduced into the multiple yop mutant (MYM)
(yadA::Tn5, yopHMEKypkA, [35]) strain by electroporation as de-
scribed previously [20]. The bacteria were grown in Luria Broth (LB)
overnight at 26 C on a rotary shaker. The cultures were then diluted
10· and incubated at 26 C for 0.5 h, followed by 1 h at 37 C to in-
duce YopH expression. For infection, the bacteria were pelleted and
washed once with prewarmed PBSA then resuspended in prewarmed
PBSA to an OD600 = 1.0 (about 1 · 109 cfu/ml).
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J774 cells were seeded in 10 cm tissue culture dishes 1 day before
infection to get about 80% conﬂuence. One hour before infection,
the medium was exchanged with fresh a-MEM without antibiotic.
For infection, the medium was removed and 1 ml of bacteria suspen-
sion was added. After incubating for 45 min at 37 C in a humidiﬁed
atmosphere with 5% CO2, the infection was stopped by removing bac-
teria and washing the cells three times with 10 ml of ice-cold 1· PBSA
containing 1 mMNa3VO4. The cells were lysed in RIPA buﬀer (50 mM
Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100, 1 mM Na3VO4, 0.5%
Na-SOC, 0.1% SDS and a cocktail of protease inhibitors (Roche Diag-
nostics Scandinavia AB). Cell lysates were centrifuged for 15 min at
14000 rpm in a microcentrifuge at 4 C, cleared cell lysates were col-
lected and protein concentrations were determined using the Bio-
Rad protein assay (Bio-Rad Laboratories). For immunoprecipitation,
cell lysates were adjusted for equivalent protein concentration (1 mg)
and volume with RIPA buﬀer, then precleared with 50 ll of 50% pro-
tein G Sepharose beads for 1 h at 4 C. The lysates were subjected to
immunoprecipitation with rabbit anti-Fyb (1:50) or anti-mAbp1
(1:100) antisera conjugated to protein G beads for 4 h at 4 C. After
extensive washing in RIPA buﬀer, immunoprecipitates were subjected
to immunoblot analysis with the anti-pTyr antibody RC20, hen anti-
mAbp1 antibody and rabbit anti-Fyb antiserum.
2.10. Immunoﬂuorescence staining
J774 cells were plated onto 12 mm glass cover slips and grown for 1
day before staining. The cells were washed, ﬁxed, permeabilized and
blocked as described previously [34], then the cover slips were inverted
into a drop of PBS (about 40 ll) containing anti-Fyb or anti-SH3p7
antibodies in a humidiﬁed chamber and incubated for 1 h. Cover slips
were washed in PBS and incubated with 5% donkey normal IgG serum
for 20 min, then incubated with secondary antibody for 1 h. All incu-
bations were at 37 C. The cover slips were ﬁnally washed and
mounted onto glass slides using ultimate mounting media (UMM)Fig. 1. Co-localization of Fyb and F-actin. J774 cells transfected with pC
pCB6GFP-Fyb 1–547 or pCB6GFP-Fyb 548–783 were ﬁxed and stained
immunoﬂuorescence microscopy.[7]. Samples were analyzed using a ﬂuorescent microscope (Zeiss) with
epiﬂuorescent illumination and a 100·/1.4 plan-apochromate oil
immersion lens. J774 cells transfected with GFP-Fyb variants were
stained for actin using phalloidin, washed and then mounted in
UMM [7]. Fluorescent images of transfected cells were obtained with
a confocal laser scanning microscope with dual detectors and an ar-
gon–krypton (Ar/Kr) laser for simultaneous scanning of the two ﬂu-
orochromes (Leica). Images of the size 1024 · 1024 were taken using
a 63·/1.32–0.6 oil immersion lens with a zoom factor of 5.01 and the
pinhole setting was 1.3 airy units.3. Results
3.1. The Fyb FPPPP motif is not required for localization to
actin rich structures
The ﬁnding of Fyb as a target of the antiphagocytic bacterial
protein, YopH [1], together with data suggesting a role for Fyb
in integrin-mediated cell adhesion [23] indicated that this adap-
tor protein is associated with signalling to the actin cytoskele-
ton. Fyb, which localizes to actin-rich structures in cells, has
previously been shown to interact with the EVH1-domain of
Ena/VASP proteins [18], a protein with potential to inﬂuence
F-actin dynamics [28]. As a ﬁrst step in the study of the role
of Fyb in macrophages and especially in phagocytosis, the
importance of the Fyb-Ena/VASP interaction for localization
of Fyb to cellular actin rich structures was investigated. J774
cells were transfected with GFP-Fyb full length 1–783, GFP-
Fyb 1–547, which lacks the EVH1-binding FPPPP motif,
GFP-Fyb 548–783, and GFP alone. Microscope analyses ofB6GFP vector as a control, pCB6GFP-Fyb 1–783 (full-length Fyb),
with phalloidin (red). The specimens were examined by confocal
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control localized to actin-rich lamellipodia (Fig. 1). This indi-
cated that the FPPPP motif not is a prerequisite for the asso-
ciation of Fyb with F-actin rich structures in cells, and that
also an additional part of the Fyb protein directly or indirectly
can mediate this interaction. Moreover, pull down experiments
using GST-Fyb 548–783 revealed that Fyb interacted with a
minor portion of total VASP in J774 lysates (supplementary
data Fig. 1).
3.2. N-terminal Fyb interacts with mAbp1 in the yeast two-
hybrid system
Fyb contains several functional domains that can mediate
protein–protein interactions. In an attempt to identify novel
Fyb binding proteins, truncated variants of Fyb encompassing
amino acids 1–339, 341–598, and 548–783, respectively, were
used as bait to screen a mouse lymphoma cDNA library using
the yeast two-hybrid system. With Fyb 1–339 as bait, we found
a positive clone that represented a 1.2 kb cDNA insert encod-
ing mouse mAbp1 149–433 amino acids. Co-transformation of
the mAbp1 cDNA with the three Fyb fragments revealed that
yeast cells containing mAbp1 together with Fyb 1–339, but not
Fyb 341–598 and 546–783 grew on plates lacking leucine, his-
tidine, uracil and adenine; the empty vector pGBKT7 was used
as control (Fig. 2A). Similar results were obtained by the b-
galactosidase activity assay (Fig. 2B).
3.3. MAbp1 is expressed in J774 cells and localizes together with
Fyb in F-actin rich areas
Mouse mAbp1 is a ubiquitously expressed protein, 433 ami-
no acids long, which can bind F-actin and it has been impli-
cated in regulation of endocytosis [36,37]. Since Fyb hasFig. 2. Interaction of Fyb with mAbp1 in the yeast two-hybrid system. Fyb
empty pGBKT7 were transformed together with mAbp 149–433 in pACTI
library screen) into the yeast strain UMY1974. (A) Growth on selective plates
Leu-Ura-His-Ade and SC-Leu-Ura plates and incubated at 30 C. (B) b-Gala
transformation were measured using the SDS–chloroform method.been identiﬁed as the YopH substrate in J774 macrophages,
these cells were chosen for further studies of the Fyb-mAbp1
interaction. Initially, RT-PCR of mRNA from J774 cells was
employed to investigate whether mAbp1 was expressed in these
cells. RT-PCR with primers for mouse mAbp1 resulted in a
single band about 1.3 kb (Fig. 3A). Sequencing of this frag-
ment conﬁrmed that the band corresponded to full-length
mouse mAbp1. The DNA fragment was further later cloned
into pGEX-Teasy vector. Puriﬁed GST-mAbp1 protein was
thereafter used to raise antibodies against mAbp1.
Immunoﬂuorescence staining of J774 cells showed that
mAbp1 localized in the perinuclear region and in the leading
edge where it co-localized with F-actin (Fig. 3B), a localization
that corresponds to that previously shown for Fyb in other cell
types [23]. Co-staining of Fyb and mAbp1 showed that these
proteins co-localized in areas with high actin dynamics, cell
edges and ruﬄes (Fig. 3C). The colocalization of Fyb and
mAbp1 was strictly observed at the cell edges and neither were
any of the proteins found in punctuate structures, resembling
adhesion structures. The latter is in agreement with previous
data shown that Fyb not localizes to adhesion structures [18].
3.4. MAbp1 binds Fyb in J774 cells
To determine if mAbp1 interacts with Fyb in macrophages,
GST-mAbp1 protein was puriﬁed and used in pull down
experiments with J774 cell lysates. The precipitated proteins
were separated on SDS–PAGE, transferred onto a PVDF
membrane and blotted with anti-Fyb antibodies. The anti-
Fyb antibody recognized two bands about 120–130 kDa in
the J774 lysate, which correspond to the two isoforms of
Fyb. These bands were also detected in the sample of GST-
mAbp1 pull down, but not in that with GST alone, indicatingtruncated domains (1–339, 341–598, 548–783) in pGBKT7 vectors and
I vector (positive clone of mouse lymphoma MATCHMARK cDNA
. Three single transformants of each transformation were spread on SC-
ctosidase assay; b-Galactosidase activity in three transformants of each
Fig. 3. Interaction of Fyb with mAbp1 in mouse macrophage-like
J774 cells. (A) RT-PCR of mAbp1; J774 cell mRNA was puriﬁed and
subjected to RT-PCR with mAbp1 primers. The PCR products were
separated on 1% agarose gel. The molecular weight marker is indicated
on the left. (B) Co-localization of mAbp1 and F-actin; J774 cells were
ﬁxed and stained with hen anti-mAbp1 antibody (green) or phalloidin
(red). The specimens were examined in a ﬂuorescence microscope. (C)
Co-localization of Fyb and mAbp1 in J774 cells; J774 cells were ﬁxed
and stained with hen anti-mAbp1 antibody (red) and rabbit anti-Fyb
antiserum (green). The specimens were examined in a ﬂuorescence
microscope. (D) GST-mAbp1 binds Fyb in J774 cell lysates; GST-
mAbp1 on beads was used to pull down Fyb from J774 cell lysates,
GST beads were used as a control. The proteins bound to the beads
were separated on SDS–PAGE gel and transferred onto PVDF
membrane, then probed with anti-Fyb antiserum. 10% lysates from
pull down experiments were loaded in the left lane.
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(Fig. 3D). Loading various concentrations of cell lysates re-
vealed that about 10% of total Fyb was pulled down with
GST-mAbp1 (data not shown).
3.5. Fyb interacts with the mAbp1 SH3 domain
The mAbp1 protein is an actin binding protein, which has a
single actin-depolymerizing factor homology (ADF-H) do-
main at its N-terminus, followed by an a-helical structure
region, a stretch with PxxP and YXXP motifs and a C-
terminal SH3 domain (Fig. 4B) [29–31]. To investigate which
part of mAbp1 was responsible for the interaction with Fyb,
diﬀerent variants of GST-mAbp1 and His-Fyb protein frag-
ments were generated for use in in vitro interaction studies
(Fig. 4A and B). For mAbp1, pGEX-mAbp1 encoding full-
length mAbp1, pGEX-mAbp1 1–146 encoding the ADF-H
domain alone, pGEX-mAbp1 1–280 encoding the ADF-H
domain and the a-helical region, pGEX-mAbp1 281–433
encoding the C-terminal half with the PxxP and YxxP regions
and the SH3 domain, and pGEX-mAbp1 371–433 with the
SH3 domain alone were expressed in BL-21 and puriﬁed on
glutathione Sepharose 4B beads. Coomassie staining of the
separated proteins revealed that all variants were expressedand had the estimated molecular weight (Fig. 4D). Similarly,
constructs encoding His-tagged Fyb protein fragments encom-
passing residues 1–339, 341–598 or 548–783 were generated
and expressed in BL-21. The bacterial lysates were subjected
to Western blotting using anti-His antibodies to conﬁrm
expression (Fig. 4C). Both Fyb and mAbp1 contain tyrosine
motifs, and to investigate if any tyrosine-phosphorylated motif
is involved in the interaction, tyrosine phosphorylated variants
of the mAbp1 and Fyb proteins were also generated. For this,
the proteins were expressed in TKX1, which carries an induc-
ible tyrosine kinase gene [38]. Western blotting using anti-
phosphotyrosine antibodies of proteins generated by TKX1
showed that all GST-mAbp1variants and His-Fyb 341–598
as well as His-Fyb 548–783 were tyrosine phosphorylated (data
not shown). The same molecular amounts of mAbp1 GST fu-
sion proteins on beads were used in pull down experiments
with bacterial lysates containing equal amounts of the diﬀerent
His-Fyb proteins. His-Fyb proteins that bound to mAbp1-
beads were detected with anti-His antibodies. In accordance
with the results of the yeast two-hybrid experiment, full-length
mAbp1 bound to Fyb 1–339, but not to Fyb 341–598 or Fyb
548–783 (Fig. 4E). In addition, both tyrosine-phosphorylated
and non-tyrosine phosphorylated mAbp1 bound to the Fyb
1–339 fragment (Fig. 4E).
To investigate which part of the mAbp1 protein was in-
volved in the interaction with Fyb, GST-mAbp1 protein vari-
ants were used in pull down experiments with His-Fyb 1–339
lysates. Here, the two C-terminal fragments mAbp1 281–433
and mAbp1 371–433, which both encompass the SH3-like do-
main, interacted with Fyb (Fig. 4F). Also here, tyrosine phos-
phorylation of the proteins was not necessary for the
interaction (Fig. 4F). No interaction was seen using the other
SH3-domain deﬁcient mAbp1 variants. Hence, the N-terminal
part of Fyb, which contains several proline-rich regions, binds
to the mAbp1 SH3 domain. To further conﬁrm that the inter-
action between mAbp1 and Fyb was mediated by a typical
SH3 domain interaction, an SH3-dominant negative mAbp1
point mutant was constructed. In this mutant, GST-
mAbp1W/A, the conserved tryptophan in the SH3 domain
[39], had been exchanged with an alanine. Pull down experi-
ments showed that GST-mAbp1W/A failed to interact with
His-Fyb 1–339 (Fig. 4G), further indicating that mAbp1 inter-
acted with Fyb through SH3-proline binding.
3.6. Fyb interacts with mAbp1 in vivo and both are tyrosine-
dephosphorylated by YopH in infected J774 cells
Prior studies have shown that the Yersinia antiphagocytic
factor, YopH, targets tyrosine-phosphorylated Fyb proteins
in J774 cells. To test whether the Fyb interacting protein,
mAbp1, is also dephosphorylated by YopH, and if bacterial
infections aﬀect the Fyb-mAbp1 interaction, J774 cells were in-
fected with variants of the Yersinia pseudotuberculosis MYM
strain before analysis. The MYM strain is defective in the
YadA, YopM, E, K, H, and YpkA virulence eﬀectors, but
the genes encoding proteins necessary for regulation, secretion
and translocation are intact [35]. In this study, we used MYM
alone, MYM expressing the PTPase active wild-type YopH
(MYMYopH), and MYM expressing a catalytically inactive
YopH (MYMYopH403C/A) [1,34]. The J774 cells were left
uninfected or infected with the diﬀerent MYM strains for
45 min. Fyb or mAbp1 antisera were thereafter used for immu-
noprecipitation of the cell lysates. The precipitated proteins
Fig. 4. The N-terminal part of Fyb binds to the mAbp1 SH3 domain. (A) Schematic representation of the His-Fyb proteins used in the study. The
proline-rich (P) region (residues 100–440), the putative nuclear localization sequence (NLS) (residues 468–505, 674–700) and the SH3-like domain
(residues 371–433) are indicated. For simplicity, the N-terminal His-tags are omitted. (B) Schematic representation of the GST-mAbp1 proteins used
in the study. The presentation of the ADF-H/coﬁlin region (residues 1–140), the a-helical structure (residues 141–280) and the SH3 domain (residues
371–433) are indicated. For simplicity, the N-terminal GSTs are omitted. (C) Expression of His-Fyb fusion proteins. Crude lysates of His fusion
proteins were subjected to SDS–PAGE and transferred to PVDF membrane then blotted with anti-His antibodies. The molecular weight markers are
indicated on the left. (D) Expression of GST-mAbp1 fusion proteins; Puriﬁed GST fusion proteins were subjected to SDS–PAGE and stained with
Coomassie Blue. The molecular weight markers are indicated on the left. (E) N-terminal Fyb interacts with mAbp1; GST-mAbp1 and GST-pmAbp1
were used to pull down His-Fyb 1–339; GST beads were included as control. The proteins bound to beads were detected with anti-His antibodies. (F)
Fyb interacts with the SH3 domain of mAbp1; Full length GST-mAbp1 and the diﬀerent truncated variants (indicated above each lane) were used to
pull down His-Fyb 1–339 in vitro. The proteins bound to beads were detected with anti-His antibodies. (G) SH3 mutant of mAbp1 fails to interact
with Fyb; GST-mAbp1 W/A mutant was used to pull down His-Fyb 1–339 in vitro, GST and GST-mAbp1 were used as controls. The proteins
bound to the beads were detected with anti-His antibodies.
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branes, and blotted with anti-pTyr, anti-Fyb or anti-mAbp1
antibodies. The results showed that both Fyb and mAbp1 in
the J774 cells were present in tyrosine-phosphorylated forms,
and that the bacterial infection caused an increased phosphor-
ylation of Fyb, but not of mAbp1 (Fig. 5A and B). Moreover,
YopH dephosphorylated both proteins (Fig. 5A and B), impli-
cating that mAbp1 might also be a substrate for this eﬀector.
In addition, in accordance with the pull down results, mAbp1
was co-immunoprecipitated with Fyb (Fig. 5C). Noteworthy,
there were no diﬀerences between the Fyb-mAbp1 interactions
detected in non-infected cells compared to cells infected with
MYM expressing the catalytically active YopH (Fig. 5C). In
accordance, co-staining of Fyb and mAbp1 in J774 cells in-
fected with this strain, showed that these two proteins were
co-localized at the cell edges also in the presence of activeYopH (supplementary data Fig. 2). Hence, Fyb-mAbp1 inter-
action is not interrupted by YopH, which is in agreement
with the observed phosphotyrosine independence of this
interaction.4. Discussion
Here we show, for the ﬁrst time, that the immune cell speciﬁc
adapter protein, Fyb, interacts with the F-actin-binding pro-
tein, mAbp1, in mouse macrophage cells. We have studied
the interaction in detail and shown that it is the C-terminal
SH3 domain of mAbp1 that interacts with the N-terminal half
of Fyb. The role and function of Fyb in macrophages has been
obscure, although the identiﬁcation of this adapter as a sub-
strate of the bacterial antiphagocytic factor, YopH, suggested
Fig. 5. YopH dephosphorylates the Fyb–mAbp1 complex in J774
cells. J774 cells were left uninfected or infected with MYM, MYMY-
opH or MYMYopHC/A for 45 min. The calculated bacteria/cell ratio
was 100:1. The infected cells were lysed, the cell lysates were sub-
jected to immunoprecipitation with rabbit anti-Fyb (A, C) or anti-
mAbp1 (B) antisera and subsequently immunoblotted with the
indicated antibodies.
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inﬂuence actin dynamics and integrin clustering in cells, but
the mechanism behind this has remained unknown. Conse-
quently, the present ﬁnding that Fyb can bind mAbp1 further
supports a role for Fyb in signalling for F-actin dynamics and
also provides additional insight into the mechanism involved.
The mAbp1 protein is a ubiquitously expressed F-actin bind-
ing protein [29,31,36]. It localizes to the perinuclear region of
cells and is speciﬁcally recruited to newly forming F-actin
structures during signalling leading to Rac activation, such
as lamellipodia in moving and spreading cells [36]. We show
that Fyb interacts with mAbp1 both in vivo and in vitro,
and that this protein complex is present in the cellular perinu-
clear region and enriched in lamellipodia structures that are di-
rected forward. In addition to the F-actin binding properties,
mAbp1 can, via its SH3 domain, interact directly with dyn-amin, the GTPase that regulates ﬁssion of endocytic vesicles
[29]. Noteworthy here is that over-expression of the dyn-
amin-binding SH3 domain has been shown to cause blockage
in endocytosis [29]. Other proteins known to interact with the
mAbp1 SH3 domain are haematopoietic progenitor kinase 1,
the presynaptic zinc ﬁnger protein, piccolo, and the Cdc42
GEF, Fgd1 [30,40,41]. The latter two binding partners have
clear connections to actin dynamics: Fgd1 can stimulate F-ac-
tin reorganization via the Rho GTPase, Cdc42 [42], and pic-
colo has been suggested to act as a scaﬀold protein that can
bind both proﬁlin and actin and is involved in synaptic vesicle
endo- and exocytosis near their site of action [40]. Given these
dual properties, it is anticipated that mAbp1 plays a role in the
coordination of endocytic and cytoskeletal activities.
The N-terminal F-actin binding ADH/coﬁlin homology do-
main, and the observed localization to F-actin rich structures
suggest that mAbp1 participate in the regulation of actin
dynamics. The yeast orthologue of mAbp1, which has also
been implicated in endocytic processes, has been found to be
an activator of the actin related protein (Arp) 2/3 complex
and is critical in regulating the actin cytoskeleton and cell
polarity in these cells [43,44]. A direct activation of Arp 2/3
by mAbp1 has not been reported. Although mAbp1 co-local-
izes with Arp 2/3 in the leading edges of newly formed lamel-
lipodia [36], the acid regions in the yeast Abp1 ADH/coﬁlin
domain, shown to be required for Arp 2/3 activating activity,
are, however, not present in mAbp1. RNAi of mAbp1 in hu-
man embryonic kidney cells has revealed that this protein is
essential for endocytosis but not for lamellipodia formation
[37]. However, this does not rule out a role for mAbp1 in di-
rectly regulating F-actin; even if F-actin dynamics leading to
membrane extensions is less likely, mAbp1 can be important
for F-actin dependent events involved in membrane invagina-
tion and vesicle traﬃcking. Both these events are essential steps
in phagocytosis, and we ﬁnd it intriguing that Fyb, which is a
target for an antiphagocytic factor in macrophages, binds to a
protein with potential to regulate F-actin-dependent vesicle
uptake. We also observed that upon infection of macrophages
with Yersinia, the antiphagocytic factor, the PTPase YopH,
dephosphorylated both Fyb and mAbp1. However, this did
not aﬀect the Fyb-mAbp1 interaction, and we speculate that
dephosphorylation of Fyb is suﬃcient to impair the function
of the complex. It has been shown previously that mAbp1,
which is tyrosine-phosphorylated by Src kinases, localizes to
areas with newly formed actin structures independent of tyro-
sine phosphorylation [36]. Our observation that the b1-integrin
engagement caused by the bacterial infection stimulates tyro-
sine phosphorylation of Fyb but not of mAbp1, supports a
model where Fyb tyrosine phosphorylation is involved in the
receptor-mediated engagement of this protein, and that
mAbp1 tyrosine phosphorylation is less important. This does
not exclude a role for mAbp1 in the phagocytic process; its po-
tential properties to coordinate F-actin and endocytosis rather
point towards a role in the phagocytic uptake and work to re-
veal the mechanism of mAbp1 in this process is therefore
ongoing.
Fyb has been shown to bind many diﬀerent molecules, such
as the tyrosine kinase Fyn [16], Ena/VASP family proteins [18],
SLP-76 [16], and Src-kinase-associated protein of 55 kDa
(SKAP-55) [45]. Interestingly, a complex of Fyb, Nck, VASP
and WASP, which is an activator of Arp 2/3 [46] has been
found to translocate to phagocytic cups upon Fcc receptor-
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and is speculated to contribute to local actin rearrangements
at this site. Fyb does not bind directly to Nck or WASP, but
it is likely that these are recruited via the SLP-76 protein that
binds Nck and Vav, a guanine exchange factor that promotes
activation of Rho GTPases of which WASP is a downstream
eﬀector. Accordingly, our ﬁnding of mAbp1 as an interactor
of Fyb suggests a possible linker of the WASP-containing
complex to the F-actin network.
Moreover, it was recently reported that mAbp1 participates
in signalling from the immunologic synapse, a macromolecular
structure at the T cell-APC interface. The mAbp1 protein was
suggested to modulate T cell activation by connecting T cell
receptors to actin cytoskeleton and endocytic processes [47].
Interestingly, Fyb has also been implicated in signalling from
the T cell receptor, where it is recruited to the forming immu-
nological synapse, and in analogy with that seen for mAbp1,
there is no requirement for Fyb in formation and T cell-APC
conjugates or actin polymerization [18,48]. In the case of
Fyb, the eﬀects were on signalling from the T cell receptor to
the integrins [24,25]. Although the role of mAbp1 in the cou-
pling of T cell receptor-mediated actin cytoskeletal rearrange-
ment with activation of integrin function remains to be
elucidated, there are common features that suggest that Fyb
and mAbp1 participate in similar events in T cells.
The present study shows that the immune cell speciﬁc adap-
ter protein Fyb interacts with mAbp1, a protein that can inﬂu-
ence cytoskeletal and endocytic events, and suggests a
potential mechanism by which Fyb can inﬂuence F-actin reor-
ganization.
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